Risk factors
Medtronic (MDT) risk factors
Item 1A of every Medtronic plc 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors32 risks5 new3 dropped12 reworded
Diabetes separation is a major new execution risk: MiniMed sold approximately 10% publicly while Medtronic retains approximately 90%.
Filed Jun 18, 2026 - FY2025 10-K risk factors30 risks
Medtronic faces intense global competition, strict medical device regulations, and pricing pressures from consolidating healthcare systems. The company relies heavily on ongoing R&D, product differentiation, and maintaining strong relationships with healthcare professionals. Operations are subject to complex international laws, tax uncertainties, and Irish legal requirements.
Filed Jun 20, 2025